共 50 条
- [22] Effects of induction and maintenance therapy with risankizumab on health-related quality of life outcomes in patients with moderately to severely active ulcerative colitis: A post-hoc analysis of Phase 2b/3 trials JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1585 - I1586
- [28] Etrolizumab demonstrated no difference among doses in symptomatic and endoscopic-based evaluation of remission in anti-TNF-α-naive patients in a post-hoc analysis of the phase 2 ulcerative colitis trial (EUCALYPTUS) JOURNAL OF CROHNS & COLITIS, 2017, 11 : S278 - S279
- [29] Characteristics of filgotinib-treated patients with Ulcerative Colitis who achieve sustained corticosteroid-free remission: Post hoc analysis of the phase 2b/3 SELECTION study JOURNAL OF CROHNS & COLITIS, 2023, 17 : 459 - 460
- [30] The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial LANCET RHEUMATOLOGY, 2023, 5 (08): : E451 - E460